220 related articles for article (PubMed ID: 12684767)
1. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
2. IGFBP2 as an immunohistochemical marker for prostatic adenocarcinoma.
Ambrosini-Spaltro A; Farnedi A; Montironi R; Foschini MP
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):318-28. PubMed ID: 21304397
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
5. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
Vorobĭova LR
Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
[TBL] [Abstract][Full Text] [Related]
6. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Yee DS; Narula N; Ramzy I; Boker J; Ahlering TE; Skarecky DW; Ornstein DK
Arch Pathol Lab Med; 2007 Jun; 131(6):902-8. PubMed ID: 17550317
[TBL] [Abstract][Full Text] [Related]
7. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.
Soylu H; Acar N; Ozbey O; Unal B; Koksal IT; Bassorgun I; Ciftcioglu A; Ustunel I
Pathol Oncol Res; 2016 Jan; 22(1):87-94. PubMed ID: 26341090
[TBL] [Abstract][Full Text] [Related]
9. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.
Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T; Ninck C; Bloch M; Mirlacher M; Koivisto PA; Helin HJ; Mihatsch MJ; Gasser TC; Bubendorf L
Int J Cancer; 2005 Feb; 113(4):619-28. PubMed ID: 15472903
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L
Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434
[TBL] [Abstract][Full Text] [Related]
13. The significance of the P504S expression pattern of high-grade prostatic intraepithelial neoplasia (HGPIN) with and without adenocarcinoma of the prostate in biopsy and radical prostatectomy specimens.
Helpap B
Virchows Arch; 2006 Apr; 448(4):480-4. PubMed ID: 16506014
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
15. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of NSAID-activated gene product in prostate cancer.
Iczkowski KA; Pantazis CG
Int J Surg Pathol; 2003 Jul; 11(3):159-66. PubMed ID: 12894347
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of angiogenin in prostate cancer and its precursors.
Katona TM; Neubauer BL; Iversen PW; Zhang S; Baldridge LA; Cheng L
Clin Cancer Res; 2005 Dec; 11(23):8358-63. PubMed ID: 16322296
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
19. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
Cardillo MR; Ippoliti F
Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
